Intravenous Immunoglobulin market Size, Share Poised to Touch USD 16,882.15 Million by 2026

Market Study Report Provides A Detailed Overview Of Intravenous Immunoglobulin Market With Respect To The Pivotal Drivers Influencing The Revenue Graph Of This Business Sphere.

Delaware, Selbyville - November 12, 2019 /MarketersMedia/ —

The Global Intravenous Immunoglobulin Market Size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research

Request a sample of this premium report titled at: https://www.marketstudyreport.com/request-a-sample/1695093?utm_source=marketersmedia.com&utm_medium=ADS

According to the Centers for Disease Control and Prevention (CDC) in 2012, the global occurrence rate of hypogammaglobulinemia was around 2 per 100,000 populations moreover, the number of people suffering this type of disease are estimated to increase during the forecast period. Growing occurrence of immunodeficiency disorders associated with the high implementation of IVIG therapies is expected to drive the segment growth significantly.

Immunoglobulins (IGs) are glycoproteins that are formed in the blood plasma in response to the antigens (Ag), which are considered as a foreign material to the host system. IGs are highly composite objects and precise in their nature. They are achieved from blood by fractionation procedure and filtered fo non-therapeutic as well as therapeutic applications. In therapeutics, they are administered intravenously for the treatment of several immunodeficiency.

The global Intravenous Immunoglobulin Market majorly is driven by rising elderly population, increasing occurrence of immunodeficiency disorders, growing implementation of IVIG procedures and increasing usage of off-label indications. Increasing number of patients with immunodeficiency disease is the primary reason for the expansion of IVIG procedures. According to the World Health Organization (WHO), there are approximately 50 diverse Primary Immune Deficiency (PID) such as X-lined hypo-gamma-globulinemia, specific antibody deficiency and others. Moreover, according to the U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from PID globally. Rising occurrences of these immune diseases is anticipated to bolster the demand for intravenous immunoglobulin treatments during the forecast period.

The demand for IVIG treatments for the primary and acquired immunodeficiency disorder is growing as it is the only available as well as most effective treatment option. Moreover, inactive lifestyle behaviors, including intake of saturated fats, sugars and salts, less physical actions, and high alcohol intake have led to the surge in the occurrence of such diseases. Increasing occurrence of such lifestyle related disease including antibody deficiency disorders and obesity are the factors anticipated to drive the global intravenous immunoglobulin market growth.

Request a discount on standard prices of this premium report titled at: https://www.marketstudyreport.com/check-for-discount/1695093?utm_source=marketersmedia.com&utm_medium=ADS

The global Intravenous Immunoglobulin Market is segmented on the basis of Application and geography. On the basis of application, the global Intravenous Immunoglobulin Market is categorized into Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP). In 2017, Hypogammaglobulinemia is estimated to dominate the application segment. The dominancy is attributed to the growing global occurrences of primary immunodeficiency diseases (PID). It is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs).

Some major key players in global Intravenous Immunoglobulin Market include Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare among others.

Table of Contents:

1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Intravenous Immunoglobulin Market Insights
4. Intravenous Immunoglobulin Market Size and Forecast by Application
5. Intravenous Immunoglobulin Market Size and Forecast by Regions
6. Company Profiles

Questions? Get them answered via https://www.marketstudyreport.com/enquiry-before-buying/1695093?utm_source=marketersmedia.com&utm_medium=ADS before taking a buying decision on this premium report titled Global Intravenous Immunoglobulin Market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com

Source URL: https://marketersmedia.com/intravenous-immunoglobulin-market-size-share-poised-to-touch-usd-1688215-million-by-2026/88933829

Source: MarketersMedia

Release ID: 88933829

Latest News

Riot police storm Hong Kong malls to nip more protests

Dec 14, 2019

HONG KONG — Riot police stormed several malls in Hong Kong on Sunday in a move to thwart more pro-democracy protests, as the city's leader heads to Beijing for talks on deepening economic integration between the semi-autonomous Chinese territory and mainland China. There were calls online urging protesters to gather in seven locations to sustain a push for political reform following a chaotic day of protests and clashes with police on Saturday, with the anti-government movement showing no signs of letting up after nearly five months. Most of the rallies didn't pan out Sunday as scores of riot police took...

Nissan ex-chairman Ghosn's lawyers want charges dismissed

Dec 14, 2019

TOKYO — The lawyers of former Nissan Chairman Carlos Ghosn, who is awaiting trial in Japan, said Thursday they have asked that financial misconduct charges against him be dismissed. They said in a statement that they filed papers in Tokyo District Court alleging prosecutorial misconduct that would prevent Ghosn from having a fair trial. The filings say the case results from unlawful collusion between prosecutors, government officials and Nissan executives to drum up allegations. The papers Ghosn's lawyers filed in Tokyo District Court last week allege collusion between the prosecutors, government officials and executives at Nissan Motor Co. to drum...

China says US has 'weaponized' visas to target exchanges

Dec 14, 2019

BEIJING — China on Wednesday accused the U.S. of having "weaponized" the issuance of visas following the reported inability of a top Chinese space program official to obtain permission to travel to a key conference in Washington. Foreign Ministry spokeswoman Hua Chunying told reporters that the head of the Chinese delegation to the International Astronautical Congress wasn't able to obtain a visa following an Oct. 12 interview, making it difficult for Chinese representatives to attend important events at the meeting. Reports said the vice chairman of the China National Space Administration, Wu Yanhua, had planned to attend the congress. Hua...

Hong Kong police say homemade bomb targeted officers

Dec 14, 2019

HONG KONG — A homemade, remote-controlled bomb intended to "kill or to harm" riot control officers was detonated as they deployed against renewed violence in Hong Kong over the weekend, police said Monday, in a further escalation of destructive street battles gripping the business hub. The "loud thud" Sunday night close to riot officers who had been clearing away a protester-built road block marked the first known use of an explosive device during protests that started in June over a contested extradition bill and have snowballed into an anti-government, anti-police and anti-China movement. "It exploded less than 2 meters (yards)...

Asian stocks gain after US, China announce truce on tariffs

Dec 14, 2019

BEIJING — Asian stock markets have risen after Washington and Beijing announced a truce on tariff hikes in a trade war. Benchmarks in Shanghai, Hong Kong and Seoul advanced. Japanese markets were closed for a holiday. President Donald Trump agreed Friday to put off planned tariff hikes this week on Chinese goods in a fight over Beijing's trade surplus and technology plans. In exchange, he said China would buy American farm goods. But the two sides reported no progress on basic disputes that sparked the 15-month-old fight that threatens global economic growth. Friday's truce "has simply temporarily halted the escalation...

Subscribe To Our Newsletter